infect
plagu
doctor
centuri
diagnosi
specif
diseas
identif
subsequ
manag
caus
agent
constant
need
inform
new
organ
emerg
exist
one
develop
resist
current
drug
vaccin
chang
epidemiolog
preval
twentyfirst
centuri
obtain
inform
never
import
popul
migrat
rel
low
cost
fli
mean
unfamiliar
infecti
diseas
may
brought
industrialis
countri
exampl
outbreak
sever
acut
respiratori
syndrom
sar
first
recognis
despit
modern
technolog
huge
input
money
took
month
agent
identifi
diagnost
test
produc
strategi
diseas
report
isol
establish
exampl
popul
migrat
result
spread
diseas
appear
swine
influenza
march
first
case
report
mexico
june
case
report
countri
thu
fulfil
criteria
pandem
challeng
ensu
decis
treatment
distribut
administr
specif
vaccin
doubt
new
fascin
diseas
continu
emerg
forens
physician
deal
infect
present
two
main
problem
first
manag
detaine
polic
personnel
contract
diseas
may
infecti
unwel
second
handl
complain
assault
includ
polic
offic
potenti
expos
infecti
latter
distress
involv
compound
part
inconsist
manag
guidelin
inde
exist
advent
human
right
legisl
increas
pressur
place
doctor
regard
consent
confidenti
detaine
therefor
prudent
preempt
situat
consult
begin
obtain
either
written
verbal
consent
detaine
allow
certain
piec
inform
disclos
agre
doctor
must
decid
whether
withhold
relev
detail
endang
live
health
work
within
custodi
other
may
close
contact
whether
deliber
issu
consent
confidenti
discuss
detail
adopt
univers
approach
detaine
decreas
risk
staff
acquir
diseas
help
stop
unnecessari
overreact
unjustifi
disclosur
sensit
inform
victim
violent
sexual
assault
openmind
approach
need
see
also
assail
known
may
possibl
make
inform
assess
risk
certain
diseas
ascertain
lifestyl
howev
assail
unknown
wise
assum
worst
chapter
aim
highlight
common
infect
encount
forens
physician
aim
dispel
urban
myth
provid
sensibl
approach
achiev
effect
manag
legal
requir
uk
environment
protect
act
control
substanc
hazard
health
regul
coshh
dispos
sharp
approv
contain
usa
divis
healthcar
qualiti
promot
dhqp
center
diseas
control
prevent
cdc
websit
provid
similar
guidanc
custodi
sharp
contain
transport
site
must
approv
type
uk
requir
contain
within
carriag
danger
good
classif
packag
label
use
transport
pressur
receptacl
regul
measur
help
minimis
risk
accident
injuri
precaut
includ
wear
glove
handl
sharp
never
bend
break
resheath
needl
dispos
sharp
bin
never
overfil
left
floor
place
eye
level
smallest
member
staff
bed
visibl
stain
bodi
fluid
handl
glove
three
accept
way
deal
contamin
bed
launder
deterg
minimum
temperatur
lower
temperatur
water
contain
deterg
ppm
chlorin
bleachdri
clean
elev
temperaturesdri
clean
cold
follow
steam
pressinginciner
consid
accept
practic
share
bed
detaine
necessari
staff
wear
mask
protect
eyewear
custodi
set
risk
infect
low
howev
singl
use
eyewash
clinic
room
contain
first
aid
kit
locat
within
polic
station
case
accident
exposur
contact
lens
remov
prior
eye
wash
exampl
good
practic
contain
within
uk
health
depart
document
state
respons
health
author
health
board
nh
trust
creat
local
guidelin
prevent
spread
bbv
health
care
set
guidelin
may
exist
work
place
case
formul
soon
possibl
forens
work
royal
militari
polic
uk
refer
good
practic
guidelin
also
prudent
prearrang
system
referr
nearest
hospit
accid
emerg
depart
genitourinari
depart
access
specialist
latter
may
consult
virolog
microbiolog
infecti
diseas
genitourinari
medicin
similar
guidanc
usa
found
guidelin
infect
control
health
care
personnel
exposur
staff
usual
result
failur
follow
accept
practic
howev
accid
happen
matter
much
care
taken
forens
physician
healthcar
profession
work
custodi
understand
constitut
risk
involv
take
detail
histori
incid
includ
type
exposur
bodi
fluid
involv
occur
inform
could
help
allay
unnecessari
anxieti
outset
ensur
recipi
exposur
refer
appropri
hospit
earliest
opportun
knowledg
precis
treatment
protocol
requir
help
abl
explain
recipi
expect
exampl
ask
provid
voluntari
baselin
blood
sampl
storag
number
followup
sampl
test
depend
natur
exposur
especi
relev
hepat
b
hbv
hepat
c
hcv
human
immunodefici
viru
hiv
usual
complet
week
rare
occas
test
may
extend
month
incid
sexual
assault
victim
ideal
refer
specialist
centr
avail
polic
station
use
last
resort
environ
often
hostil
readi
access
necessari
treatment
ongo
manag
see
organ
may
utilis
one
rout
eas
understand
infect
discuss
chapter
classifi
accord
primari
rout
ie
transmiss
blood
bodi
fluid
contact
lesion
organ
respiratori
rout
faecalor
rout
hbv
endem
throughout
world
popul
show
vari
degre
preval
approxim
million
peopl
infect
hbv
million
chronic
infect
worldwid
hbv
kill
million
peopl
year
develop
safe
effect
vaccin
world
health
organis
recommend
hbv
vaccin
incorpor
nation
immunis
programm
countri
chronic
infect
rate
higher
countri
although
countri
achiev
goal
end
poorest
countri
often
highest
preval
unabl
afford
particular
includ
china
indian
subcontin
subsaharan
africa
peopl
earli
stage
infect
chronic
carrier
statu
defin
persist
hepat
b
surfac
antigen
hbsag
beyond
month
transmit
infect
unit
kingdom
overal
preval
chronic
hbv
around
detail
breakdown
shown
tabl
incub
period
approxim
week
month
name
viru
primarili
affect
liver
typic
symptom
includ
malais
anorexia
nausea
mild
fever
abdomin
discomfort
may
last
day
week
insidi
onset
jaundic
joint
pain
skin
rash
may
also
occur
due
immun
complex
format
infect
newborn
usual
asymptomat
major
patient
acut
hbv
make
full
recoveri
develop
immun
follow
acut
infect
patient
develop
liver
failur
may
result
death
chronic
infect
develop
around
neonat
children
adult
neonat
children
usual
asymptomat
adult
may
mild
symptom
may
also
asymptomat
approxim
chronic
infect
individu
depend
age
acquisit
develop
cirrhosi
number
year
may
also
result
liver
failur
seriou
complic
includ
hepatocellular
carcinoma
though
latter
rare
overal
mortal
rate
hbv
estim
less
person
deem
infecti
hbsag
detect
blood
acut
phase
ill
long
month
definit
hbsag
persist
time
person
deem
carrier
carrier
usual
infecti
life
degre
infect
depend
stage
diseas
marker
tabl
major
rout
includ
parenter
eg
needlestick
injuri
bite
unscreen
blood
transfus
tattoo
acupunctur
dental
procedur
equip
inadequ
sterilis
mucou
membran
exposur
includ
mouth
eye
genit
mucou
membran
contamin
broken
skin
especi
h
old
hbv
occup
hazard
anyon
may
come
contact
blood
bloodstain
bodi
fluid
rout
describ
saliva
alon
may
transmit
hbv
saliva
peopl
infect
hbv
shown
contain
hbvdna
concentr
found
serum
especi
relev
penetr
bite
wound
infect
follow
exposur
bodi
fluid
eg
bile
urin
faec
csf
never
unless
fluid
contamin
blood
intraven
drug
user
share
needl
equip
also
risk
hbv
also
transmit
unprotect
sexual
contact
whether
homosexu
heterosexu
risk
increas
blood
involv
victim
sexual
assault
includ
categori
evid
shown
viru
may
also
spread
among
member
close
household
contact
thought
kiss
toothbrush
razor
bath
towel
etc
rout
transmiss
probabl
appli
institutionalis
patient
avail
data
studi
prison
western
countri
shown
higher
preval
hbv
bbv
gener
popul
commonli
report
risk
factor
intraven
drug
use
howev
real
transmiss
bbv
british
prison
unknown
due
compil
reliabl
data
hbv
transmit
vertic
mother
babi
perinat
period
around
babi
born
mother
either
acut
chronic
hbv
becom
infect
develop
chronic
hbv
limit
administr
hbv
vaccin
neonat
industrialis
countri
antenat
mother
screen
hbv
vaccin
given
neonat
ideal
within
first
h
birth
least
two
dose
given
design
interv
recommend
matter
cours
women
countri
preval
high
howev
practic
administ
vaccin
store
correct
temperatur
limit
access
medic
care
mean
signific
failur
vaccin
uptak
respons
industrialis
countri
hbv
vaccin
recommend
deem
risk
acquir
diseas
occup
exposurehomosexualbisexu
menintraven
drug
userssexu
partner
peopl
acut
chronic
hbvfamili
member
peopl
acut
chronic
hbvnewborn
babi
whose
mother
infect
hbv
mother
hbeag
posit
hbvspecif
immunoglobulin
hbsig
given
time
first
dose
vaccineinstitutionalis
patient
prison
ideal
hbv
vaccin
administ
prior
exposur
routin
schedul
rs
consist
three
dose
vaccin
given
month
antibodi
level
check
week
last
dose
titr
greater
miuml
adequ
respons
achiev
uk
consid
provid
protect
year
one
dose
would
given
usa
initi
adequ
respons
achiev
dose
vaccin
consid
necessari
vaccin
administr
exposur
vari
accord
time
incid
degre
risk
involv
whether
individu
alreadi
partli
fulli
vaccin
acceler
schedul
third
dose
given
month
first
dose
booster
year
later
use
prevent
perinat
transmiss
risk
greatest
may
necessari
use
rapid
schedul
rd
dose
given
day
present
booster
dose
month
schedul
current
licenc
engerix
b
hbig
may
also
use
either
alon
conjunct
vaccin
exact
dose
given
agedepend
must
administ
deep
intramuscular
inject
differ
site
vaccin
adult
usual
gluteu
muscl
hbig
given
conjunct
first
dose
vaccin
individu
deem
high
risk
acquir
diseas
incid
occur
within
h
present
also
use
neonat
born
mother
hbeagposit
adult
fail
respond
routin
schedul
vaccin
full
cours
vaccin
tri
deem
nonrespond
individu
involv
highrisk
exposur
given
two
dose
hbig
administ
month
apart
ideal
first
dose
given
within
h
exposur
longer
week
exposur
measur
includ
minimis
risk
exposur
adopt
safe
work
practic
outlin
section
univers
precaut
potenti
exposur
dealt
soon
possibl
industrialis
countri
blood
blood
product
organ
routin
screen
hbv
intraven
drug
user
encourag
vaccin
avoid
share
needl
drug
paraphernalia
see
manag
custodi
section
bacteria
associ
abscess
format
inject
drug
user
staff
victim
contact
diseas
wise
procedur
place
immedi
manag
risk
evalu
exampl
shown
fig
forens
physician
expect
administ
treatment
often
inform
person
concern
expect
tabl
outlin
treatment
protocol
use
unit
kingdom
detaine
diseas
usual
manag
custodi
detaine
bleed
cell
deem
action
left
profession
clean
contamin
bed
dealt
describ
section
contamin
bed
detaine
chronic
hbv
antivir
agent
eg
lamivudin
treatment
cours
continu
possibl
hcv
endem
part
world
approxim
million
world
popul
infect
hcv
mani
countri
reliabl
preval
data
exist
seropreval
studi
carri
among
blood
donor
shown
highest
preval
exist
egypt
ascrib
contamin
needl
use
treatment
schistosomiasi
carri
intermedi
preval
exist
eastern
europ
mediterranean
middl
east
indian
subcontin
part
africa
asia
western
europ
central
america
australia
limit
region
africa
includ
south
africa
preval
low
previous
america
includ
low
preval
group
report
publish
indic
almost
million
american
ie
popul
antibodi
hcv
repres
either
ongo
previou
infect
also
state
hcv
account
approxim
acut
viral
hepat
america
lowest
preval
found
uk
scandinavia
howev
within
countri
certain
group
higher
chanc
carri
hcv
uk
given
tabl
incub
period
week
acut
phase
diseas
last
approxim
year
unlik
hepat
hav
hbv
patient
usual
asymptomat
therefor
diseas
often
miss
unless
individu
report
specif
exposur
monitor
case
found
chanc
rais
liver
enzym
found
routin
blood
test
silent
phase
follow
acut
phase
viru
lie
dormant
liver
enzym
usual
normal
period
last
approxim
year
reactiv
may
occur
subsequ
viral
replic
damag
hepatocyt
liver
enzym
rise
moder
high
level
eighti
percent
individu
hcv
antibodyposit
infecti
regardless
level
liver
enzym
approxim
peopl
develop
chronic
infect
one
fifth
progress
cirrhosi
much
stronger
associ
hepatocellular
carcinoma
hbv
estim
patient
hcvrelat
cirrhosi
develop
liver
cancer
less
chronic
case
resolv
spontan
approxim
case
parenter
eg
needlestick
etc
transmiss
sexual
rout
common
appear
signific
repeat
exposur
one
peopl
infect
hcv
mothertobabi
transmiss
consid
uncommon
report
theoret
household
spread
also
possibl
share
contamin
toothbrush
razor
sinc
diseas
often
silent
need
rais
awar
among
gener
popul
avoid
infect
encourag
highrisk
group
test
healthcar
profession
also
educ
avoid
acquir
infect
exampl
good
practic
contain
within
document
hepat
c
strategi
england
issu
depart
health
blood
bloodstain
bodi
fluid
need
involv
risk
occur
saliva
alon
deem
risk
risk
singl
needlestick
incid
rang
contact
contamin
cut
estim
penetr
bite
injuri
data
consid
risk
blood
involv
blood
bloodstain
bodi
fluid
involv
transmiss
mucou
membran
exposur
may
account
lower
expect
preval
among
gay
popul
follow
immedi
manag
flow
chart
make
sure
avail
inform
obtain
inform
design
hospit
andor
specialist
soon
possibl
contact
known
thought
immunocompromis
consent
provid
blood
sampl
import
tell
specialist
antibodi
test
may
spurious
neg
instanc
differ
test
use
polymeras
chain
reaction
pcr
detect
viral
rna
staff
membervictim
ask
provid
baselin
sampl
blood
sampl
week
week
test
neg
week
risk
deem
high
followup
may
continu
week
followup
sampl
posit
origin
baselin
sampl
test
ascertain
whether
infect
acquir
particular
exposur
chronic
hcv
may
treatabl
combin
pegyl
nonpegyl
interferon
ribavirin
treatment
success
depend
upon
mani
factor
includ
diseas
stage
viral
genotyp
treatment
earli
stage
infect
nearli
alway
success
regardless
genotyp
earli
detect
import
detaine
diseas
unless
sever
ill
detaine
manag
custodi
special
precaut
requir
bleed
custodi
staff
wear
glove
contact
blood
like
contamin
bed
handl
appropri
cell
clean
profession
use
defect
transmiss
viru
discov
requir
hbv
worldwid
distribut
associ
hbv
approxim
million
peopl
infect
preval
hdv
higher
southern
itali
middl
east
part
africa
south
america
occur
greater
asymptomat
hbv
carrier
greater
chronic
hbvrelat
liver
diseas
despit
high
preval
hbv
china
south
east
asia
hdv
countri
rare
hdv
associ
acut
coinfect
chronic
hepat
superinfect
exacerb
preexist
liver
damag
caus
hbv
rout
transmiss
atrisk
group
hbv
staffvictim
contact
put
exposur
detaine
diseas
manag
hbv
interferonalpha
eg
roferon
use
treat
patient
chronic
hbv
hdv
though
would
practic
continu
treatment
custodi
set
hiv
first
identifi
year
first
report
made
cdc
atlanta
ga
increas
incid
two
unusu
diseas
kaposi
sarcoma
pneumocysti
carinii
pneumonia
occur
among
gay
popul
san
francisco
scale
viru
gradual
emerg
year
end
estim
million
peopl
throughout
world
live
hiv
aid
world
total
live
africa
india
report
unaid
state
one
five
adult
lesotho
malawi
mozambiqu
swaziland
zambia
zimbabw
hiv
aid
also
expect
sharp
rise
case
hiv
china
papua
new
guinea
countri
asia
pacif
next
year
uk
end
cumul
data
report
individu
hiv
aid
includ
death
aid
report
though
like
underestim
end
hiv
preval
increas
onethird
undiagnos
group
still
consid
greatest
risk
acquir
hiv
unit
kingdom
men
sex
men
msm
age
infect
among
intraven
drug
user
overal
estim
preval
london
figur
higher
user
edinburgh
dunde
report
hiv
posit
major
die
new
diagnos
made
nearli
half
black
african
year
hiv
infect
acquir
heterosexu
within
uk
incid
mothertobabi
transmiss
estim
europ
around
africa
transmiss
rate
among
african
women
thought
much
higher
due
combin
women
endstag
diseas
higher
viral
load
concomit
placent
infect
render
permeabl
viru
use
antiretrovir
therapi
pregnanc
togeth
advic
avoid
breastfeed
prove
efficaci
reduc
vertic
horizont
transmiss
among
hiv
posit
women
western
world
third
world
countri
realiti
stark
access
treatment
limit
realist
substitut
breast
milk
provid
valuabl
sourc
antibodi
lifethreaten
infect
patient
receiv
blood
transfus
organ
blood
product
screen
routin
carri
must
also
includ
incub
estim
week
month
exposur
depend
extent
abil
current
laboratori
test
detect
hiv
antibodi
viral
antigen
major
case
diagnos
within
week
develop
pcr
viral
rna
improv
sensit
acut
phase
infect
experi
seroconvers
flulik
ill
individu
infecti
time
viral
antigen
present
blood
antibodi
start
form
viral
antigen
disappear
individu
enter
latent
phase
noninfecti
remain
well
variabl
period
time
year
develop
aid
mark
phase
diseas
viral
antigen
reemerg
individu
infecti
onset
aid
consider
delay
use
treatment
parenter
transmiss
includ
needl
stick
injuri
bite
unscreen
blood
tattoo
acupunctur
dental
procedur
equip
inadequ
sterilis
risk
transmiss
increas
deep
penetr
injuri
hollow
bore
needl
visibl
bloodstain
especi
devic
previous
sourc
patient
contact
arteri
vein
rout
includ
mucou
membran
exposur
eye
mouth
genit
mucou
contamin
broken
skin
higher
viral
load
contact
greater
risk
transmiss
like
termin
stage
infect
hiv
transmit
mainli
blood
bodi
fluid
visibl
bloodstain
except
semen
vagin
fluid
breast
milk
saliva
alon
unlik
transmit
infect
therefor
peopl
sustain
penetr
bite
injuri
reassur
risk
provid
contact
bleed
mouth
time
risk
singl
percutan
exposur
hollow
bore
needl
low
singl
mucocutan
exposur
even
less
like
result
infect
risk
sexual
exposur
vari
though
appear
greater
risk
recept
anal
intercours
compar
recept
vagin
intercours
highrisk
fluid
includ
blood
semen
vagin
fluid
breast
milk
littl
risk
saliva
urin
vomit
faec
unless
visibl
bloodstain
fluid
constitut
theoret
risk
includ
csf
periton
pleural
pericardi
fluid
manag
custodi
staffvictim
contact
diseas
includ
follow
immedi
manag
flow
chart
fig
contact
design
detail
exposur
possibl
obtain
blood
contact
like
hbv
hcv
blood
sampl
taken
hiv
test
taken
inform
consent
unit
kingdom
need
forens
physician
go
detail
mean
test
contact
encourag
attend
genitourinari
depart
similar
design
hospit
discuss
test
result
contact
refus
blood
sampl
inform
lifestyl
ethnic
origin
state
health
etc
may
use
specialist
decid
whether
postexposur
prophylaxi
pep
given
recipi
saliva
involv
penetr
bite
injuri
everi
justif
reassur
recipi
littl
risk
acquir
hiv
howev
still
wise
take
advic
specialist
unit
kingdom
current
recommend
regim
pep
one
truvada
tablet
mg
tenofovir
mg
emtricitaban
ftc
day
plu
two
kaletra
filmcoat
tablet
mg
lopinavir
mg
ritonavir
twice
day
given
follow
signific
exposur
highrisk
fluid
visibl
bloodstain
contact
known
highli
like
hiv
posit
ideal
treatment
start
within
hour
exposur
certainli
within
h
extenu
circumst
beyond
remit
chapter
may
allow
pep
given
longer
period
follow
exposur
usual
given
week
unless
contact
subsequ
identifi
hiv
neg
recipi
develop
toler
toxic
occur
weekli
followup
recipi
take
place
treatment
improv
adher
monitor
drug
toxic
deal
concern
use
inform
may
influenc
decis
whether
treat
standard
regim
use
altern
drug
includ
interact
medic
recipi
may
take
contact
antiretrovir
therapi
recipi
pregnant
data
exist
efficaci
pep
beyond
occup
exposur
pep
consid
exposur
low
risk
fluid
rout
sourc
unknown
eg
discard
needl
despit
appropri
use
time
pep
report
failur
unless
sever
ill
kept
custodi
everi
effort
made
continu
treatment
may
receiv
appli
univers
precaut
deal
detaine
ensur
contamin
cell
andor
bed
manag
appropri
case
highli
infecti
diseas
occur
throughout
year
frequent
winter
earli
spring
season
endem
appear
blur
global
warm
uk
highest
preval
occur
year
age
group
nineti
percent
popul
age
immun
similar
preval
report
part
western
europ
usa
south
east
asia
varicella
mainli
diseas
adulthood
therefor
peopl
born
countri
move
uk
like
suscept
chicken
pox
strong
correl
histori
chicken
pox
serolog
adult
born
live
industrialis
countri
uncertain
neg
histori
chicken
pox
also
seroposit
march
liveattenu
vaccin
licenc
use
usa
polici
children
suscept
healthcar
personnel
introduc
uk
glaxosmithklin
launch
liveattenu
vaccin
call
varilrix
decemb
depart
health
follow
advic
joint
committe
vaccin
immunis
jcvi
recommend
vaccin
given
nonimmun
healthcar
worker
like
direct
contact
individu
chicken
pox
healthcar
worker
previou
histori
chicken
pox
screen
immun
antibodi
found
receiv
two
dose
vaccin
week
apart
vaccin
current
recommend
children
given
pregnanc
follow
incub
period
day
may
shorter
immunocompromis
usual
prodrom
flulik
ill
onset
rash
coryz
phase
like
adult
lesion
typic
appear
crop
rapidli
progress
red
papul
vesicl
open
sore
crust
separ
day
distribut
rash
centripet
ie
trunk
face
limb
convers
small
pox
adult
diseas
often
sever
lesion
involv
scalp
mucou
membran
oropharynx
children
diseas
often
mild
unless
immunocompromis
unlik
experi
complic
adult
defin
year
older
rather
differ
secondari
bacteri
infect
common
rare
seriou
increas
likelihood
perman
scar
haemorrhag
chickenpox
typic
occur
second
third
day
rash
usual
limit
bleed
skin
lifethreaten
melaena
epistaxi
haematuria
occur
varicella
pneumonia
rang
patchi
lung
consolid
overt
pneumon
occur
case
occur
previous
healthi
individu
particularli
adult
risk
increas
smoke
immunocompromis
peopl
greatest
risk
develop
complic
run
fulmin
cours
commonest
caus
varicellaassoci
death
fibrosi
perman
respiratori
impair
may
occur
surviv
suspicion
lung
involv
indic
immedi
treatment
detaine
staff
member
sent
hospit
involv
cn
includ
varieti
condit
includ
mening
enceph
latter
common
immunocompromis
fatal
taken
day
first
lesion
appear
end
new
vesicl
format
last
vesicl
crust
typic
day
onset
may
last
day
primari
rout
direct
contact
open
lesion
chicken
pox
howev
also
spread
aerosol
droplet
respiratori
tract
chicken
pox
may
also
acquir
contact
open
lesion
shingl
varicella
zoster
less
like
shingl
less
infecti
chicken
pox
nonimmun
individu
risk
acquir
diseas
approxim
adult
popul
born
uk
adult
usa
fall
categori
therefor
like
chicken
pox
encount
custodi
set
involv
peopl
born
outsid
uk
particular
south
east
asia
individu
immunocompromis
lost
immun
nonimmun
pregnant
women
risk
develop
complic
pneumonia
occur
pregnant
women
chicken
pox
sever
appear
increas
later
gestat
also
transmit
infect
unborn
babi
infect
acquir
first
week
chanc
lead
congenit
varicella
syndrom
infect
last
trimest
lead
neonat
varicella
unless
day
elaps
onset
matern
rash
deliveri
antibodi
time
cross
placenta
lead
either
mild
inappar
infect
newborn
situat
varicella
immunoglobulin
vzig
administ
babi
soon
possibl
birth
staff
chicken
pox
stay
work
end
infect
period
approxim
day
contact
diseas
known
nonimmun
histori
diseas
contact
design
occup
health
physician
detaine
diseas
kept
custodi
possibl
especi
pregnant
women
unavoid
nonimmun
immunocompromis
staff
avoid
enter
cell
close
contact
detaine
nonimmun
immunocompromis
pregnant
individu
expos
chickenpox
seek
expert
medic
advic
administr
vzig
aciclovir
similar
antivir
agent
given
soon
possibl
immunocompromis
peopl
chicken
pox
also
consid
anyon
year
old
like
develop
complic
anyon
suspect
sever
complic
sent
straight
hospit
chicken
pox
viru
lie
dormant
dorsal
root
cranial
nerv
may
reemerg
typic
involv
one
dermatom
site
involv
depend
sensori
ganglion
initi
involv
shingl
common
age
except
immunocompromis
attack
occur
earlier
age
latter
also
suscept
secondari
attack
involv
one
dermatom
bilater
zoster
even
rarer
associ
higher
mortal
uk
estim
incid
per
year
may
prodrom
period
paraesthesia
burn
shoot
pain
involv
segment
usual
follow
appear
band
rare
vesicl
fail
appear
pain
experienc
known
zoster
sine
herpet
individu
immunocompromis
diseas
may
prolong
dissemin
may
occur
rare
fatal
shingl
pregnanc
usual
mild
foetu
affect
viraemia
occur
matern
antibodi
time
cross
placenta
common
complic
shingl
postherpet
neuralgia
occur
case
defin
pain
last
day
rash
onset
frequent
peopl
lead
depress
rare
children
includ
immunocompromis
infect
brain
includ
enceph
involv
motor
neuron
lead
ptosi
paralysi
hand
facial
palsi
contralater
hemiparesi
involv
oculomotor
divis
trigemin
ganglion
caus
seriou
eye
problem
includ
corneal
scar
shingl
far
less
infecti
chicken
pox
consid
day
lesion
appear
shingl
infecti
follow
prolong
contact
lesion
unlik
airborn
transmiss
risk
individu
immunocompromis
may
reactiv
dormant
viru
develop
shingl
peopl
primari
varicella
risk
develop
chicken
pox
follow
prolong
direct
contact
shingl
despit
popular
belief
untru
immunocompet
peopl
chicken
pox
develop
shingl
contact
either
chicken
pox
shingl
occurr
mere
coincident
unless
immun
lower
staff
shingl
stay
work
lesion
heal
unless
cover
staff
chicken
pox
immun
includ
pregnant
women
therefor
risk
nonimmun
usual
accept
without
histori
chickenpox
avoid
prolong
contact
detaine
shingl
pregnant
nonimmun
women
avoid
contact
altogeth
detaine
diseas
may
kept
custodi
expos
lesion
cover
well
document
prompt
treatment
attenu
sever
diseas
reduc
durat
viral
shed
hasten
lesion
heal
reduc
sever
durat
pain
also
reduc
likelihood
develop
postherpet
neuralgia
prompt
treatment
famciclovir
mg
td
day
exampl
initi
onset
day
less
also
consid
time
detaine
pregnant
detaine
shingl
reassur
minim
risk
mother
unborn
child
expert
advic
sort
initi
treatment
mother
tini
parasit
mite
sarcopt
scabiei
infest
human
year
expert
estim
excess
million
case
occur
worldwid
year
femal
mite
burrow
skin
especi
around
hand
feet
male
genitalia
min
egg
laid
hatch
larva
travel
skin
surfac
newli
develop
mite
mite
caus
intens
itch
often
wors
night
aggrav
heat
moistur
irrit
spread
outsid
origin
point
infect
due
allerg
reaction
mite
faec
irrit
may
persist
week
treatment
allevi
antihistamin
crust
scabi
far
sever
form
diseas
larg
area
bodi
may
involv
crust
hide
thousand
live
mite
egg
make
difficult
treat
socal
norwegian
scabi
common
elderli
immunocompromis
especi
hiv
follow
primari
exposur
take
week
onset
itch
howev
exposur
reduc
incub
time
around
day
without
treatment
assum
indefinit
treatment
person
consid
infecti
mite
egg
destroy
usual
day
crust
scabi
highli
infecti
sinc
transmiss
direct
skintoskin
contact
infect
case
glove
worn
deal
individu
suspect
infest
usual
prolong
contact
need
unless
person
crust
scabi
transmiss
occur
easili
risk
transmiss
much
greater
household
repeat
prolong
contact
like
sinc
mite
surviv
bed
cloth
h
glove
also
worn
handl
item
bed
treat
use
one
method
profession
clean
cell
warrant
case
crust
scabi
prefer
treatment
scabi
either
permethrin
cream
aqueou
malathion
either
treatment
appli
whole
bodi
left
least
h
case
permethrin
h
malathion
wash
lindan
longer
consid
treatment
choic
may
complic
pregnanc
treatment
custodi
may
practic
consid
detaine
thought
norwegian
scabi
like
scabi
head
lice
occur
worldwid
found
hair
close
scalp
egg
nit
cling
hair
difficult
remov
harm
see
nit
sure
lice
also
present
latter
best
seen
hair
wet
lice
bite
scalp
suck
blood
caus
intens
irrit
itch
pass
direct
hair
hair
contact
necessari
wear
glove
examin
head
whatev
reason
cell
need
clean
use
sinc
lice
live
near
skin
bed
may
contamin
shed
skin
handl
glove
launder
inciner
presenc
live
lice
indic
treatment
either
physic
remov
comb
applic
insecticid
latter
may
practic
custodi
aqueou
malathion
appli
dri
hair
wash
h
hair
shampoo
normal
commonli
found
pubic
axillari
chest
leg
hair
howev
eyelash
eyebrow
may
also
involv
associ
peopl
bath
chang
cloth
regularli
person
usual
complain
intens
itch
irrit
main
rout
person
person
direct
contact
egg
stick
fibr
cloth
bed
handl
care
see
section
staff
alway
wear
glove
like
come
contact
hirsut
bodi
part
cloth
bed
handl
glove
either
launder
inciner
treatment
detaine
custodi
good
theori
probabl
impract
whole
bodi
treat
flea
lay
egg
floor
carpet
bed
uk
fleabit
come
cat
dog
egg
larva
flea
surviv
month
reactiv
respons
anim
human
activ
sinc
anim
flea
jump
human
bite
detaine
fleabit
flea
unless
human
flea
treatment
necessari
flea
seen
use
cell
vacuum
clean
proprietari
insecticid
bed
remov
wear
glove
bag
either
launder
inciner
bedbug
live
lay
egg
wall
floor
furnitur
bed
look
care
faecal
track
may
seen
hard
surfac
present
long
enough
emit
distinct
odour
bedbug
rare
found
person
may
brought
cloth
person
effect
bedbug
bite
night
caus
sleep
disturb
detaine
need
treat
cell
deem
use
vacuum
profession
clean
insecticid
solut
bed
cloth
handl
glove
dispos
appropri
staphylococcu
aureu
commonli
carri
skin
nose
healthi
peopl
approxim
popul
colonis
bacteria
remain
well
time
time
bacteria
caus
minor
skin
infect
usual
requir
antibiot
treatment
howev
seriou
problem
occur
eg
infect
surgic
wound
drug
inject
site
osteomyel
pneumonia
septicaemia
last
year
bacteria
becom
increasingli
resist
penicillinbas
antibiot
last
year
increas
number
altern
antibiot
multiresist
bacteria
known
methicillinresist
aureu
mrsa
mrsa
preval
worldwid
like
nonresist
staphylococci
may
remain
undetect
reservoir
colonis
individu
also
produc
clinic
diseas
common
among
elderli
debilit
immunocompromis
peopl
open
wound
cluster
skin
infect
mrsa
report
among
inject
drug
user
sinc
america
recent
similar
strain
found
uk
idu
commun
may
particular
relev
forens
physician
deal
inject
drug
user
sore
immunocompet
peopl
rare
get
mrsa
consid
risk
april
decemb
record
case
communityacquir
mrsa
inject
drug
user
england
wale
bacteria
usual
spread
via
hand
staff
contact
colonis
infect
detaine
devic
item
eg
bed
towel
soil
dress
environment
surfac
contamin
mrsacontain
bodi
fluid
either
known
suspect
case
consid
abscessesulc
inject
drug
user
infecti
standard
precaut
appli
staff
wear
glove
touch
mucou
membran
nonintact
skin
blood
bodi
fluid
item
could
contamin
also
encourag
wash
hand
antimicrobi
agent
whether
glove
worn
use
glove
dispos
yellow
hazard
bag
allow
touch
surfac
mask
gown
worn
carri
procedur
gener
aerosol
blood
bodi
fluid
sinc
unlik
scenario
custodi
set
necessari
glove
worn
handl
bed
cloth
item
dispos
appropri
manner
open
wound
cover
soon
possibl
cell
clean
profession
use
risk
contamin
last
decad
increas
awar
bacteri
flora
colonis
inject
site
may
potenti
lead
lifethreaten
infect
sudden
increas
needl
abscess
caus
clonal
strain
group
streptococcu
report
among
hospitalis
idu
bern
switzerland
recent
studi
uk
show
predomin
isol
aureu
streptococcu
speci
form
one
fifth
betahaemolyt
streptococci
also
report
nonspor
spore
anaerob
eg
bacteroid
clostridia
speci
includ
clostridium
botulinum
term
number
inject
drug
use
one
import
risk
factor
group
streptococc
infect
unit
kingdom
account
recent
number
case
fallen
year
year
particular
laboratori
glasgow
report
isol
c
novyi
among
idu
seriou
unexplain
ill
june
total
case
definit
probabl
report
definit
case
defin
idu
sever
local
system
inflammatori
reaction
probabl
case
defin
idu
present
hospit
abscess
signific
inflamm
inject
site
either
sever
inflammatori
process
around
inject
site
sever
system
reaction
multiorgan
failur
high
white
cell
count
uk
presenc
c
botulinum
infect
inject
site
rel
new
phenomenon
end
case
report
phl
sinc
number
increas
total
case
uk
eir
report
sinc
begin
thought
case
associ
contamin
batch
heroin
simultan
inject
cocain
increas
risk
encourag
anaerob
condit
anaerob
flora
wound
may
seriou
consequ
detaine
risk
transmiss
staff
virtual
nonexist
end
cumul
total
suspect
case
report
unit
kingdom
case
occur
england
four
case
report
alon
recent
decemb
two
inject
drug
user
scotland
die
anthrax
contamin
heroin
follow
two
death
occur
england
februari
alert
issu
first
depart
health
nation
treatment
agenc
warn
drug
user
possibl
risk
spore
bacillu
anthraci
contamin
heroin
without
obviou
sign
anthrax
acquir
inject
smoke
inhal
heroin
obviou
symptom
includ
excess
swell
red
inject
site
fever
headach
short
breath
heroin
smoke
user
advis
go
straight
emerg
depart
worri
infect
spore
form
bacteria
alway
occur
time
time
healthcar
practition
mind
time
staff
remind
wear
glove
come
contact
detaine
infect
skin
site
exud
pu
serum
old
dress
found
cell
dispos
yellow
bag
mark
clinic
wast
medic
room
likewis
bed
bag
launder
inciner
use
cell
deem
use
profession
clean
detaine
gone
healthcar
profession
manag
detaine
clean
dress
open
wound
soon
possibl
prevent
spread
infect
may
also
appropri
start
cours
antibiot
abscess
format
sign
cellul
andor
detaine
system
unwel
howev
infect
often
lowgrad
skin
venou
lymphat
system
damag
repeat
penetr
skin
case
sign
includ
lymphoedema
swollen
lymph
gland
darkli
pigment
skin
area
fever
may
may
present
septicaemia
uncommon
unless
individu
immunocompromis
eg
hiv
posit
coamoxiclav
prefer
treatment
choic
cover
major
staphylococci
streptococci
anaerob
dose
use
depend
degre
infect
necrotis
fasciiti
septic
thrombophleb
rare
lifethreaten
complic
iv
drug
use
detaine
suspect
either
need
hospit
treatment
advic
harm
reduct
also
given
includ
encourag
drug
user
smoke
rather
inject
least
advis
avoid
inject
muscl
skin
although
inject
drug
user
awar
risk
share
needl
may
realis
share
drug
paraphernalia
could
hazard
advic
given
use
minimum
amount
citric
acid
dissolv
heroin
acid
damag
tissu
skin
allow
bacteria
flourish
drug
inject
differ
site
use
fresh
work
inject
particularli
import
snowbal
crack
cocain
creat
anaerob
environ
medic
help
request
inject
site
becom
pain
swollen
show
sign
pu
collect
skin
sinc
intraven
drug
user
increas
risk
acquir
hbv
hav
inform
vaccin
diseas
advis
anoth
seriou
rel
rare
problem
risk
broken
needl
vein
embolis
take
anyth
hour
day
even
longer
remov
complic
may
includ
endocard
pericard
pulmonari
abscess
ivdu
advis
seek
medic
help
soon
possibl
case
present
custodi
send
detaine
straight
hospit
examin
victim
assault
children
adult
present
like
lateamong
polic
offic
bitten
arrest
detaineein
detaine
arrest
dog
usedwher
detaine
involv
fight
either
around
time
arrest
earlier
detail
forens
examin
bite
given
bite
penetr
skin
goal
therapi
minimis
soft
tissu
deform
prevent
treat
infect
uk
usa
dog
bite
repres
approxim
threequart
bite
present
accid
emerg
depart
singl
dog
bite
produc
psi
crush
forc
addit
torsion
forc
dog
shake
head
result
massiv
tissu
damag
human
bite
may
caus
classic
bite
punctur
wound
eg
impact
fist
teeth
result
crush
injuri
estim
dog
bite
human
bite
lead
infect
compar
estim
nonbit
wound
manag
accid
emerg
depart
risk
infect
increas
punctur
wound
hand
injuri
full
thick
wound
wound
requir
debrid
involv
joint
tendon
ligament
fractur
comorbid
medic
condit
diabet
asplenia
chronic
oedema
area
liver
dysfunct
presenc
prosthet
valv
joint
immunocompromis
state
may
also
increas
risk
infect
infect
may
spread
beyond
initi
site
lead
septic
arthriti
osteomyel
endocard
periton
septicaemia
mening
inflamm
tendon
synovi
line
joint
may
also
occur
enough
forc
use
bone
may
fractur
wound
may
perman
disfigur
assess
whether
hospit
treatment
necessari
made
soon
possibl
alway
refer
wound
bleed
heavili
fail
stop
pressur
appli
penetr
bite
involv
arteri
nerv
muscl
tendon
hand
feet
result
moderatetoseri
facial
wound
crush
injuri
also
requir
immedi
referr
manag
within
custodi
appropri
ask
current
tetanu
statu
hbv
vaccin
statu
known
allergi
antibiot
wound
breach
skin
irrig
isoton
sodium
chlorid
ringer
lactat
solut
prefer
antisept
latter
may
delay
wound
heal
full
forens
document
bite
made
detail
note
clinic
sign
infect
erythema
oedema
cellul
purul
discharg
region
lymphadenopathi
cover
wound
steril
nonadhes
dress
wound
closur
gener
recommend
data
suggest
may
increas
risk
infect
particularli
relev
nonfaci
wound
deep
punctur
wound
bite
hand
clinic
infect
wound
occur
h
present
head
neck
wound
cosmet
import
area
may
close
less
h
old
obvious
infect
bacteria
dog
bite
pasteurella
cani
p
multocida
aureu
staphylococci
streptococcu
speci
eikenella
corroden
corynebacterium
speci
anaerob
includ
bacteroid
fragili
c
tetanihuman
bite
streptococcu
speci
aureu
e
corroden
anaerob
includ
bacteroid
often
penicillin
resist
peptostreptococci
speci
c
tetani
tb
syphili
may
also
transmit
virus
dog
bite
outsid
uk
australia
new
zealand
rabi
consid
usa
domest
dog
mostli
vaccin
rabi
polic
dog
vaccin
common
sourc
racoon
skunk
batshuman
bite
hbv
hcv
hiv
herp
simplex
antibiot
gener
need
wound
day
old
sign
infect
superfici
noninfect
wound
evalu
earli
left
open
heal
secondari
intent
compliant
peopl
signific
comorbid
antibiot
consid
highrisk
wound
involv
hand
feet
face
tendon
ligament
joint
suspect
fractur
penetr
bite
injuri
person
diabet
asplenia
cirrhosi
immunosuppress
coamoxiclav
amoxycillin
clavulan
acid
firstlin
treatment
dog
human
bite
result
infect
manag
primari
care
adult
recommend
dose
mg
td
children
mgkg
td
base
amoxycillin
compon
treatment
continu
day
also
firstlin
drug
prophylaxi
samedos
regim
prescrib
day
individu
known
suspect
allerg
penicillin
tetracyclin
eg
doxycyclin
mg
bd
metronidazol
mg
td
aminoglycosid
eg
erythromycin
metronidazol
use
uk
doxycyclin
use
restrict
usa
year
old
specialist
advic
sort
pregnant
women
anyon
sever
infect
clinic
unwel
refer
hospit
tetanu
vaccin
given
primari
cours
last
booster
year
ago
human
tetanu
immunoglobulin
consid
tetanuspron
wound
eg
soil
contamin
punctur
wound
sign
devitalis
tissu
wound
sustain
h
old
person
never
immunis
unsur
tetanu
statu
full
threedos
cours
space
least
month
apart
given
penetr
bite
wound
involv
saliva
may
present
risk
hbv
perpetr
belong
highrisk
group
manag
see
diseas
prevent
manag
custodi
section
hepat
b
hcv
hiv
risk
blood
involv
relev
manag
dealt
manag
custodi
section
hepat
c
manag
custodi
staffvictim
contact
diseas
section
human
immunodefici
viru
respiratori
tract
infect
common
usual
mild
selflimit
though
may
requir
symptomat
treatment
paracetamol
nonsteroid
antiinflammatori
includ
common
cold
rhinovirus
coronavirus
adenovirus
influenza
parainfluenza
summer
earli
autumn
enterovirus
special
attent
given
asthmat
immunocompromis
detaine
infect
peopl
may
seriou
particularli
lower
respiratori
tract
involv
follow
section
includ
respiratori
pathogen
special
note
may
pose
risk
detaine
andor
staff
come
close
contact
five
serogroup
neisseria
meningitidi
b
c
preval
differ
type
vari
countri
countri
current
avail
vaccin
type
b
two
vaccin
c
acwi
avail
overal
uk
popul
carri
n
meningitidi
age
group
unit
kingdom
case
mening
sporad
less
occur
cluster
outbreak
among
school
children
case
group
b
group
c
account
season
variat
high
level
case
winter
low
level
summer
greatest
risk
group
peak
incid
year
old
secondari
peak
occur
yearsold
age
group
subsaharan
africa
diseas
preval
dri
season
mani
countri
background
endem
year
round
preval
serogroup
routin
vaccin
group
c
introduc
uk
novemb
everybodi
age
firstyear
univers
student
sinc
extend
includ
everyon
age
result
introduct
vaccin
programm
reduct
group
c
case
reduct
year
old
outbreak
serogroup
mening
occur
among
pilgrim
hajj
case
report
mani
countri
includ
uk
uk
offici
requir
vaccin
quadrival
vaccin
acwi
vax
go
pilgrimag
hajj
umra
illeg
immigr
may
enter
countri
vaccin
follow
incub
period
day
diseas
onset
may
either
insidi
mild
prodrom
symptom
florid
earli
symptom
sign
includ
malais
fever
vomit
sever
headach
neck
stiff
photophobia
drowsi
rash
may
develop
rash
may
petechi
purpur
characterist
blanch
pressur
mening
infant
like
insidi
onset
lack
classic
sign
approxim
case
septicaemia
predomin
featur
even
prompt
antibiot
treatment
case
fatal
rate
mening
septicaemia
person
consid
infecti
bacteria
longer
present
nasal
discharg
treatment
usual
approxim
h
diseas
spread
infect
droplet
direct
contact
carrier
clinic
ill
requir
prolong
close
contact
greater
risk
peopl
share
accommod
utensil
kiss
must
also
rememb
unprotect
mouthtomouth
resuscit
also
transmit
diseas
possibl
tell
detaine
carrier
nevertheless
risk
acquir
infect
even
infect
sick
individu
low
unless
carri
mouthtomouth
resuscit
staff
member
think
place
risk
report
occup
health
depart
equival
nearest
emerg
depart
earliest
opportun
vaccin
perform
mouthtomouth
resuscit
prophylact
antibiot
given
receiv
vaccin
rifampicin
ciprofloxacin
ceftriaxon
use
howev
ciprofloxacin
number
advantag
singl
dose
mg
adult
children
need
fewer
side
effect
contraind
rifampicin
ceftriaxon
given
inject
therefor
best
avoid
custodi
set
staff
member
pregnant
advic
sought
consult
obstetrician
ciprofloxacin
recommend
anyon
deal
regular
basi
illeg
immigr
especi
middl
east
subsaharan
africa
eg
immigr
servic
custodi
staff
design
station
medic
personnel
interpret
consid
vaccin
acwi
vax
singl
inject
provid
protect
year
detaine
suspect
diseas
sent
directli
hospit
human
tuberculosi
tb
caus
infect
mycobacterium
tuberculosi
bovi
africanum
notifi
diseas
legisl
specif
individu
countri
exampl
uk
come
public
health
control
diseas
act
declar
tb
global
emerg
estim
million
new
case
million
death
occur
year
major
asia
africa
howev
statist
like
underestim
sinc
depend
accuraci
report
poorer
countri
surveil
system
often
inadequ
lack
fund
even
uk
inconsist
report
particularli
individu
concomit
infect
hiv
physician
found
caught
dilemma
confidenti
code
practic
updat
encourag
report
patient
consent
advent
rapid
identif
test
treatment
use
bcg
vaccin
prevent
tb
declin
first
half
twentieth
centuri
uk
howev
sinc
earli
number
slowli
increas
case
report
report
case
peopl
born
outsid
uk
associ
hiv
infect
london
identifi
area
signific
problem
attribut
highli
mobil
popul
varieti
ethnic
group
high
preval
hiv
emerg
drugresist
strain
phl
unpublish
data
mycobnet
similar
pictur
initi
found
usa
revers
longstand
downward
trend
howev
number
case
increas
also
seriou
outbreak
multidrugresist
tb
mdrtb
hospit
new
york
citi
miami
factor
pertin
overal
upsw
includ
emerg
hiv
increas
number
immigr
countri
high
preval
tuberculosi
perhap
significantli
stop
categor
feder
fund
control
activ
latter
led
failur
public
health
infrastructur
tb
control
sinc
trend
revers
cdc
transfer
fund
tuberculosi
surveil
treatment
programm
state
larg
citi
annual
declin
averag
follow
year
reduc
indic
room
complac
proactiv
redirect
fund
countri
need
octob
global
partnership
call
stop
tb
launch
coordin
everi
aspect
tb
control
partnership
member
state
target
set
detect
least
case
year
acquisit
tuberculosi
infect
necessarili
follow
diseas
infect
may
heal
spontan
may
take
week
month
becom
appar
infect
may
remain
dormant
year
reactiv
later
life
especi
person
becom
debilit
immunocompromis
contrari
popular
belief
major
case
tb
immunocompet
peopl
pass
unnot
report
case
involv
lung
nonrespiratori
eg
bone
heart
kidney
brain
dissemin
miliari
tb
common
immigr
ethnic
group
immunocompromis
also
like
develop
resist
strain
gener
popul
estim
lifetim
risk
tuberculosi
infect
progress
diseas
increas
number
case
tuberculosi
associ
hiv
either
due
new
infect
reactiv
tuberculosi
infect
like
progress
activ
tb
hiv
posit
individu
greater
lifetim
risk
tb
also
lead
worsen
hiv
increas
viral
load
therefor
need
earli
diagnosi
paramount
difficult
pulmonari
tb
may
present
nonspecif
featur
eg
bilater
unilater
lower
lobe
shadow
incub
week
symptom
may
develop
see
tabl
main
rout
airborn
infect
droplet
prolong
close
contact
need
nonrespiratori
diseas
consid
risk
unless
mycobacterium
aerosolis
except
circumst
eg
surgeri
open
abscess
person
consid
infecti
long
viabl
bacilli
found
induc
sputum
untreat
incomplet
treat
peopl
may
intermitt
sputumposit
year
follow
week
appropri
treatment
individu
usual
consid
noninfecti
period
often
extend
treatment
mdrtb
concomit
hiv
patient
complianc
also
play
import
factor
risk
infect
directli
proport
degre
exposur
sever
diseas
occur
malnourish
immunocompromis
eg
hiv
etc
substanc
misus
immunocompromis
peopl
special
risk
mdrtb
mycobacterium
aviumintracellular
mai
staff
diseas
stay
work
treatment
cours
complet
serial
sputum
sampl
longer
contain
bacilli
staff
contact
diseas
vaccin
bcg
low
risk
acquir
diseas
minimis
time
spent
cell
receiv
bcg
immunocompromis
avoid
contact
detaine
wherev
possibl
detaine
mai
pose
risk
staff
member
unless
latter
immunocompromis
staff
member
pregnant
regardless
bcg
statu
type
tb
avoid
contact
togeth
anyon
perform
mouthtomouth
resuscit
person
untreat
suspect
pulmonari
tb
regard
household
contact
report
occup
health
gp
rout
exist
also
educ
symptom
tb
anyon
like
come
repeat
contact
individu
risk
tb
receiv
bcg
alreadi
done
regardless
age
even
though
evid
suggest
bcg
administ
adult
life
less
effect
appli
immunocompromis
individu
pregnant
women
latter
case
vaccin
prefer
defer
deliveri
detaine
diseas
whether
suspect
diagnos
treat
treatment
incomplet
kept
custodi
minimum
time
possibl
immunocompromis
individu
tb
usual
ill
detain
consid
greater
risk
transmit
diseas
staff
detaine
diseas
encourag
cover
mouth
nose
cough
sneez
staff
wear
glove
contact
detaine
handl
cloth
bed
bed
bag
use
launder
inciner
cell
deem
action
ventil
profession
decontamin
although
hard
evid
support
risk
transmiss
rout
march
issu
global
warn
health
author
new
atyp
pneumonia
call
sar
earliest
case
believ
origin
guandong
provinc
china
novemb
caus
agent
identifi
new
corona
viru
sarscov
end
june
case
report
differ
countri
total
death
approxim
case
occur
china
includ
hong
kong
taiwan
macao
case
fatal
rate
vari
peopl
less
year
old
person
age
year
age
group
person
older
juli
report
last
human
chain
transmiss
sar
broken
lift
ban
countri
howev
warn
everyon
remain
vigil
resurg
sar
still
possibl
inde
prove
case
report
ongo
may
sinc
report
case
knowledg
epidemiolog
ecolog
sarscov
diseas
remain
limit
howev
experi
gain
previou
outbreak
enabl
diseas
contain
rapidli
reflect
case
report
sinc
decemb
still
specif
treatment
prevent
vaccin
develop
date
incub
period
short
around
day
maximum
day
despit
media
frenzi
surround
initi
outbreak
sar
less
infecti
influenza
follow
clinic
case
definit
sar
develop
public
health
purpos
person
histori
fever
least
one
symptom
lower
respiratori
tract
ill
cough
difficulti
breath
dyspnoea
radiograph
evid
lung
infiltr
consist
pneumonia
respiratori
distress
syndrom
post
mortem
find
identifi
causeand
altern
diagnosi
fulli
explain
ill
laboratori
test
develop
includ
detect
viral
rna
pcr
nasopharyng
secret
stool
sampl
detect
antibodi
elisa
ifa
blood
viral
cultur
clinic
specimen
avail
inform
suggest
close
contact
via
aerosol
infect
droplet
infect
individu
provid
highest
risk
acquir
diseas
case
occur
hospit
worker
care
index
case
close
famili
member
despit
reemerg
sar
highli
unlik
case
encount
custodi
set
time
write
howev
forens
physician
need
remain
alert
symptom
sar
keep
uptod
recent
outbreak
inform
obtain
daili
basi
web
site
sar
suspect
medic
staff
wear
glove
surgic
mask
examin
suspect
case
howev
mask
usual
avail
custodi
anyon
suspect
sar
must
sent
immedi
hospit
staff
prolong
close
contact
alert
potenti
symptom
consist
featur
diseas
transmit
faecalor
rout
diarrhoea
see
tabl
infect
agent
includ
bacteria
virus
protozoa
sinc
caus
numer
beyond
remit
chapter
cover
safest
treat
diarrhoea
infecti
unless
detaine
proven
noninfecti
caus
eg
crohn
diseas
ulcer
coliti
staff
wear
glove
contact
detaine
handl
cloth
bed
etc
contamin
articl
launder
inciner
cell
profession
clean
use
pay
particular
attent
toilet
area
viral
hepat
occur
worldwid
variabl
preval
highest
countri
hygien
poor
infect
occur
year
round
temper
climat
peak
incid
autumn
winter
trend
becom
less
mark
age
group
suscept
nonimmun
vaccin
develop
countri
diseas
occur
earli
childhood
wherea
revers
true
countri
standard
live
higher
uk
gradual
decreas
number
report
case
due
part
improv
standard
live
introduct
effect
vaccin
highest
incid
occur
age
group
approxim
peopl
age
natur
immun
leav
remaind
suscept
infect
small
cluster
occur
time
time
associ
breakdown
hygien
also
increas
incid
hav
gay
bisexu
men
partner
unpublish
studi
london
show
seropreval
among
gay
men
young
et
al
unpublish
clinic
pictur
rang
asymptomat
infect
spectrum
fulmin
hepat
unlik
hbv
hcv
hav
persist
progress
chronic
liver
damag
infect
childhood
often
mild
asymptomat
adult
tend
sever
follow
incub
period
day
mean
day
symptomat
infect
start
abrupt
onset
jaundic
anyth
day
week
anicter
phase
last
approxim
length
time
often
accompani
sudden
onset
fever
hav
infect
lead
hospit
admiss
age
group
like
increas
age
durat
stay
overal
mortal
less
peopl
prolong
relaps
ill
month
cdc
fact
sheet
fulmin
hepat
occur
peopl
like
age
preexist
liver
diseas
hospitalis
patient
case
fatal
rang
form
year
old
nearli
older
year
individu
infecti
week
onset
jaundic
asymptomat
make
control
infect
difficult
sinc
diseas
recognis
main
rout
faecalor
ingest
contamin
water
food
also
transmit
close
person
contact
includ
homosexu
practis
anal
intercours
fellatio
slight
risk
blood
transfus
donor
acut
phase
infect
consid
risk
needlestick
injuri
unless
clinic
suspicion
hav
high
risk
group
includ
homeless
homosexu
ivdu
travel
abroad
vaccin
patient
chronic
liver
diseas
chronic
infect
hbv
hcv
employe
resid
daycar
centr
hostel
sewag
worker
laboratori
technician
handl
nonhuman
primat
sever
larg
outbreak
occur
among
inject
drug
user
epidemiolog
link
prison
transmiss
occur
viraem
phase
ill
share
inject
equip
via
faecalor
rout
poor
live
condit
also
report
hav
transmit
drug
carri
rectum
studi
vancouv
show
inject
drug
user
past
infect
hav
also
show
increas
preval
among
men
sex
men
staff
diseas
report
occup
health
stay
work
end
infect
period
contact
diseas
either
exposur
home
infect
detaine
receiv
prophylact
treatment
soon
possibl
see
minimis
risk
acquir
diseas
custodi
staff
wear
glove
deal
detaine
wash
hand
thoroughli
glove
dispos
clinic
wast
bag
detaine
diseas
kept
custodi
minimum
time
possibl
sent
hospit
fulmin
hepat
suspect
cell
quarantin
use
profession
clean
bed
cloth
handl
glove
launder
inciner
accord
local
detaine
report
contact
diseas
given
prophylact
treatment
soon
possibl
see
section
prophylaxi
treatment
contact
hav
receiv
hav
vaccin
eg
havrix
monodos
avaxim
previous
immunis
diseas
human
normal
immunoglobulin
hnig
mg
deep
im
gluteal
muscl
use
follow
circumst
contact
cirrhosi
preexist
hbv
hcv
hdvcontact
occur
day
day
exposur
staff
higher
risk
come
contact
hav
consid
vaccin
prior
exposur
two
dose
vaccin
given
month
apart
give
least
year
protect
specif
treatment
hav
except
support
measur
symptomat
treatment
although
chanc
encount
tropic
diseas
custodi
small
worth
bear
mind
necessari
forens
physician
abl
diagnos
specif
diseas
simpli
recognis
detaineestaff
member
ill
whether
need
sent
hospit
see
tabl
best
achiev
know
right
question
ask
carri
appropri
examin
tabl
use
aid
memoir
order
miss
unusu
diseas
